Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial.


Journal

Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 15 06 2019
accepted: 21 09 2019
entrez: 3 10 2019
pubmed: 3 10 2019
medline: 12 5 2020
Statut: epublish

Résumé

Dyslipidaemia and low-grade inflammation are central in atherogenesis and linked to overweight and physical inactivity. Lifestyle changes are important in secondary prevention of coronary artery disease (CAD). We compared the effects of combined weight loss and interval training with interval training alone on physical fitness, body composition, dyslipidaemia and low-grade inflammation in overweight, sedentary participants with CAD. Seventy CAD patients, BMI 28-40 kg/m Twenty-six (74%) AIT and 29 (83%) LED + AIT participants completed the study. At baseline subject included 43 (78%) men; subjects averages were: age 63 years (6.2), body weight 95.9 kg (12.2) and VO Both interventions were feasible. Both groups obtained improvements in VO

Sections du résumé

BACKGROUND
Dyslipidaemia and low-grade inflammation are central in atherogenesis and linked to overweight and physical inactivity. Lifestyle changes are important in secondary prevention of coronary artery disease (CAD). We compared the effects of combined weight loss and interval training with interval training alone on physical fitness, body composition, dyslipidaemia and low-grade inflammation in overweight, sedentary participants with CAD.
METHODS
Seventy CAD patients, BMI 28-40 kg/m
RESULTS
Twenty-six (74%) AIT and 29 (83%) LED + AIT participants completed the study. At baseline subject included 43 (78%) men; subjects averages were: age 63 years (6.2), body weight 95.9 kg (12.2) and VO
CONCLUSIONS
Both interventions were feasible. Both groups obtained improvements in VO

Identifiants

pubmed: 31575375
doi: 10.1186/s12933-019-0934-x
pii: 10.1186/s12933-019-0934-x
pmc: PMC6774219
doi:

Substances chimiques

Biomarkers 0
Inflammation Mediators 0
Lipids 0
PLAUR protein, human 0
Receptors, Urokinase Plasminogen Activator 0
TNF protein, human 0
Tumor Necrosis Factor-alpha 0
C-Reactive Protein 9007-41-4

Banques de données

ClinicalTrials.gov
['NCT01724567']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

127

Références

Eur J Sport Sci. 2017 Oct;17(9):1203-1211
pubmed: 28792851
J Am Heart Assoc. 2014 Oct 23;3(5):e001118
pubmed: 25341887
Arch Intern Med. 2007 Jan 8;167(1):31-9
pubmed: 17210875
J Intern Med. 2010 Sep;268(3):296-308
pubmed: 20561148
Am Heart J. 2006 Oct;152(4):793-800
pubmed: 16996860
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12
pubmed: 26764059
Am Heart J. 2008 Aug;156(2):292-300
pubmed: 18657659
Eur Heart J. 2013 May;34(17):1258-61
pubmed: 23376447
Cardiovasc Diabetol. 2018 Sep 12;17(1):126
pubmed: 30208900
Atherosclerosis. 2015 Dec;243(2):364-72
pubmed: 26520888
Am Heart J. 2012 Apr;163(4):666-76.e1-3
pubmed: 22520533
Diabetologia. 2019 Jun;62(6):1048-1064
pubmed: 31011777
Arch Intern Med. 2006 Apr 24;166(8):860-6
pubmed: 16636211
Obesity (Silver Spring). 2009 Sep;17(9):1768-75
pubmed: 19498345
Circulation. 2011 Dec 20;124(25):2829-38
pubmed: 22104550
J Am Coll Cardiol. 2013 Feb 5;61(5):553-60
pubmed: 23369419
BMC Cardiovasc Disord. 2013 Nov 19;13:106
pubmed: 24252596
Nature. 2006 Dec 14;444(7121):881-7
pubmed: 17167477
J Sci Med Sport. 2018 Mar;21(3):286-290
pubmed: 28728886
Int J Cardiol. 2013 Jul 31;167(2):403-8
pubmed: 22265582
Cardiovasc Diabetol. 2017 Mar 14;16(1):37
pubmed: 28292300
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Inflamm Res. 2014 Mar 21;7:45-55
pubmed: 24715762
Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):447-54
pubmed: 20485181
Circulation. 2000 May 9;101(18):2149-53
pubmed: 10801754
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
N Engl J Med. 1988 Nov 3;319(18):1173-9
pubmed: 3173455
Lipids Health Dis. 2011 Jul 18;10:119
pubmed: 21767400
Eur J Prev Cardiol. 2016 Apr;23(6):636-48
pubmed: 25687109
Atherosclerosis. 2016 Mar;246:221-8
pubmed: 26803431
Am J Clin Nutr. 2006 Dec;84(6):1317-23
pubmed: 17158411
Cardiovasc Drugs Ther. 2006 Jun;20(3):205-17
pubmed: 16775666
Lancet. 1997 Feb 15;349(9050):462-6
pubmed: 9040576
Circulation. 2009 May 26;119(20):2671-8
pubmed: 19433757
J Am Coll Cardiol. 2009 Dec 29;55(1):35-41
pubmed: 20117361
J Appl Physiol (1985). 2007 Feb;102(2):634-40
pubmed: 17095635
Circulation. 2013 Sep 10;128(11):1189-97
pubmed: 24002795
N Engl J Med. 2010 Nov 25;363(22):2102-13
pubmed: 21105792
N Engl J Med. 2013 Jul 11;369(2):145-54
pubmed: 23796131
J Am Coll Cardiol. 2012 Oct 9;60(15):1374-80
pubmed: 22958953
N Engl J Med. 2011 Mar 31;364(13):1218-29
pubmed: 21449785
Biomark Insights. 2014 Dec 16;9:91-100
pubmed: 25574132
Obes Res. 2003 Sep;11(9):1055-64
pubmed: 12972675
Eur J Prev Cardiol. 2015 Aug;22(8):1009-17
pubmed: 25082954
Circulation. 1983 May;67(5):968-77
pubmed: 6219830
Int J Cardiol. 2013 Aug 10;167(3):781-5
pubmed: 22459389
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Cardiovasc Diabetol. 2017 Aug 30;16(1):110
pubmed: 28854979
Acta Physiol Scand. 1956 Dec 31;38(2):193-9
pubmed: 13394341
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Stroke. 2012 Dec;43(12):3305-12
pubmed: 23150653
Adv Clin Chem. 2008;46:295-317
pubmed: 19004193
Eur Heart J. 2002 Dec;23(23):1854-60
pubmed: 12445534
Arterioscler Thromb Vasc Biol. 1995 Mar;15(3):299-305
pubmed: 7749838
Ann Intern Med. 2000 Jul 18;133(2):92-103
pubmed: 10896648
N Engl J Med. 2002 Nov 7;347(19):1483-92
pubmed: 12421890
Eur Heart J. 2014 Mar;35(9):578-89
pubmed: 24026779

Auteurs

Lene Rørholm Pedersen (LR)

Department of Cardiology, Bispebjerg University Hospital, University of Copenhagen, Building 67, 1st, Bispebjerg Bakke 23, 2400, Copenhagen, NW, Denmark. lrpedersen@gmail.com.
Department of Cardiology, University Hospital of Zealand, Roskilde, University of Copenhagen, Copenhagen, Denmark. lrpedersen@gmail.com.

Rasmus Huan Olsen (RH)

Department of Cardiology, Bispebjerg University Hospital, University of Copenhagen, Building 67, 1st, Bispebjerg Bakke 23, 2400, Copenhagen, NW, Denmark.

Christian Anholm (C)

Department of Internal Medicine, Glostrup University Hospital, University of Copenhagen, Copenhagen, Denmark.

Arne Astrup (A)

Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.

Jesper Eugen-Olsen (J)

Clinical Research Centre, Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark.

Mogens Fenger (M)

Department of Medical Biochemistry, Genetics and Molecular Biochemistry, Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark.

Lene Simonsen (L)

Department of Clinical Physiology and Nuclear Medicine, Bispebjerg University Hospital, University of Copenhagen, Copenhagen, Denmark.

Rosemary L Walzem (RL)

Faculty of Nutrition, Texas A & M University, College Station, TX, USA.

Steen Bendix Haugaard (SB)

Department of Internal Medicine, Amager and Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark.

Eva Prescott (E)

Department of Cardiology, Bispebjerg University Hospital, University of Copenhagen, Building 67, 1st, Bispebjerg Bakke 23, 2400, Copenhagen, NW, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH